Equities

National Research Corp

National Research Corp

Actions
Health CareHealth Care Providers
  • Price (USD)19.47
  • Today's Change-0.50 / -2.50%
  • Shares traded70.17k
  • 1 Year change-57.36%
  • Beta0.5164
Data delayed at least 15 minutes, as of Oct 07 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of three primary solution categories: Marketing, Reputation and Experience. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools to evaluate the needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. The Company's Experience solutions are provided on a subscription basis via a cross-continuum multi-mode digital platform. Its Reputation solutions allow healthcare organizations to share a picture of their organization.

  • Revenue in USD (TTM)146.28m
  • Net income in USD29.26m
  • Incorporated1997
  • Employees435.00
  • Location
    National Research Corp1245 Q StLINCOLN 68508United StatesUSA
  • Phone+1 (402) 475-2525
  • Fax+1 (402) 475-9061
  • Websitehttps://nrchealth.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Performant Financial Corp119.23m-6.34m269.39m958.00--3.54--2.26-0.0824-0.08241.550.98631.17--5.45124,452.00-6.24-10.44-7.18-13.50-----5.32-9.97---3.770.0954--4.18-6.08-15.02---11.53--
Resources Connection Inc599.57m12.21m274.97m3.38k22.920.675313.430.45860.35840.358417.7712.171.16--5.04177,596.902.367.452.799.1938.2039.272.045.53----0.0046.98-18.42-2.79-61.31-7.74-30.191.89
Ambipar Emergency Response510.24m13.40m282.69m7.09k21.101.173.920.5540.24170.24179.214.370.6352.903.7171,975.643.60--4.61--18.85--5.72--2.214.390.5904--53.72---138.69------
Montana Technologies Corp0.00195.08m324.06m--1.581.411.66--3.673.670.004.120.00------79.52--81.19--------------0.00-------39.13------
Lesaka Technologies Inc564.22m-16.65m403.41m2.53k--1.8353.760.715-0.2694-0.26949.142.741.0319.4318.10222,924.50-2.94-6.20-3.67-7.7921.5422.82-2.86-10.521.440.35360.4753--6.8728.5652.53--3.71--
Serve Robotics Inc1.52m-32.78m414.93m57.00--12.58--272.91-0.9094-0.90940.0420.77920.08052.4832.6526,673.33-173.52---260.51---8.53---2,156.35--7.07-7.260.0768--92.50---13.54------
Cross Country Healthcare, Inc.1.58bn8.49m421.93m10.83k54.190.94915.710.26790.23030.230345.5313.152.29--4.33145,441.001.2410.931.6214.7521.3322.790.53913.98--13.230.000.00-28.0419.86-61.46--24.90--
Acacia Research Corp152.55m60.47m449.68m170.0014.180.8025.242.950.31590.31591.325.590.23682.3512.19897,370.6010.758.2212.3710.3379.7680.0145.3963.9610.90--0.1208--111.24-0.9935141.45--183.16--
National Research Corporation146.28m29.26m464.77m435.0016.1811.5613.203.181.201.206.021.681.16--13.27336,275.9023.1626.2533.7836.7761.9263.2020.0123.95--32.450.512355.45-1.974.42-2.580.669521.45-5.29
ACCO Brands Corp1.73bn-176.00m501.98m5.60k--0.8126--0.2895-1.83-1.8318.026.450.66193.184.36309,607.20-6.721.63-8.342.0633.3330.71-10.152.501.093.060.613556.10-5.89-1.14-65.15---16.554.56
ZKH Group Ltd (ADR)1.26bn-59.60m544.23m4.66k--1.19--0.433-0.3683-0.36837.742.82------269,630.90--------17.05---2.66--1.61--0.1603--4.88--22.54------
Cass Information Systems Inc218.45m27.44m549.13m1.06k20.242.3916.802.511.991.9915.8416.850.0919--2.70205,890.701.151.3310.6710.7090.9396.7112.5617.21----0.735852.0813.847.00-13.88-0.089626.636.60
International Money Express Inc666.16m58.47m563.79m1.11k10.273.967.840.84631.681.6819.204.371.16--4.12600,146.9010.1512.4716.0219.28----8.789.27--8.900.59730.0020.4719.193.81--18.62--
Willdan Group, Inc.551.90m17.13m608.76m1.62k35.172.8418.761.101.241.2439.8315.311.35--3.89341,522.304.20-0.77776.72-1.1135.1634.023.10-0.7331--3.100.3105--18.8713.38229.331.7336.36--
Data as of Oct 07 2024. Currency figures normalised to National Research Corp's reporting currency: US Dollar USD

Institutional shareholders

34.38%Per cent of shares held by top holders
HolderShares% Held
Kayne Anderson Rudnick Investment Management LLCas of 31 Mar 20243.03m12.68%
BlackRock Fund Advisorsas of 31 Mar 2024929.91k3.90%
The Vanguard Group, Inc.as of 31 Mar 2024905.79k3.79%
Atlanta Capital Management Co. LLCas of 31 Mar 2024885.53k3.71%
Dimensional Fund Advisors LPas of 30 Jun 2024584.35k2.45%
Renaissance Technologies LLCas of 30 Jun 2024432.88k1.81%
Geode Capital Management LLCas of 30 Jun 2024407.69k1.71%
SSgA Funds Management, Inc.as of 31 Mar 2024354.35k1.48%
Invesco Advisers, Inc.as of 31 Mar 2024344.45k1.44%
QV Investors, Inc.as of 30 Jun 2024338.38k1.42%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.